Nyberg S - Search Results

1

The relevance of serotonergic mechanisms in the treatment of schizophrenia has not been confirmed.

Nyberg S, Farde L. Nyberg S, et al. J Psychopharmacol. 1997;11(1):13-4. doi: 10.1177/026988119701100103. J Psychopharmacol. 1997. PMID: 9097884 No abstract available.

2

Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole.

Nyberg S, Olsson H, Nilsson U, Maehlum E, Halldin C, Farde L. Nyberg S, et al. Psychopharmacology (Berl). 2002 Jun;162(1):37-41. doi: 10.1007/s00213-002-1083-5. Epub 2002 May 14. Psychopharmacology (Berl). 2002. PMID: 12107615 Clinical Trial.

3

PET imaging of neuroreceptors in schizophrenia.

Sedvall G, Pauli S, Karlsson P, Farde L, Nordström AL, Nyberg S, Halldin C. Sedvall G, et al. Among authors: nyberg s. Eur Neuropsychopharmacol. 1995;5 Suppl:25-30. doi: 10.1016/0924-977x(95)00021-g. Eur Neuropsychopharmacol. 1995. PMID: 8775755 Review.

4

Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.

Andrée B, Nyberg S, Ito H, Ginovart N, Brunner F, Jaquet F, Halldin C, Farde L. Andrée B, et al. Among authors: nyberg s. J Clin Psychopharmacol. 1998 Aug;18(4):317-23. doi: 10.1097/00004714-199808000-00012. J Clin Psychopharmacol. 1998. PMID: 9690698

5

Implications of brain imaging for the management of schizophrenia.

Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L. Nyberg S, et al. Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S15-20. doi: 10.1097/00004850-199803003-00003. Int Clin Psychopharmacol. 1998. PMID: 9690965 Review.

6

Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies.

Nyberg S, Farde L. Nyberg S, et al. Psychopharmacology (Berl). 2000 Jan;148(1):22-3. doi: 10.1007/s002130050020. Psychopharmacology (Berl). 2000. PMID: 10663413 No abstract available.

7

High 5HT2A receptor occupancy in M100907-treated schizophrenic patients.

Talvik-Lotfi M, Nyberg S, Nordström AL, Ito H, Halldin C, Brunner F, Farde L. Talvik-Lotfi M, et al. Among authors: nyberg s. Psychopharmacology (Berl). 2000 Mar;148(4):400-3. doi: 10.1007/s002130050069. Psychopharmacology (Berl). 2000. PMID: 10928313 Clinical Trial.

8

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.

Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B. Nyberg S, et al. Psychopharmacology (Berl). 1993;110(3):265-72. doi: 10.1007/BF02251280. Psychopharmacology (Berl). 1993. PMID: 7530376 Clinical Trial.

9

Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.

Varnäs K, Nyberg S, Karlsson P, Pierson ME, Kågedal M, Cselényi Z, McCarthy D, Xiao A, Zhang M, Halldin C, Farde L. Varnäs K, et al. Among authors: nyberg s. Psychopharmacology (Berl). 2011 Feb;213(2-3):533-45. doi: 10.1007/s00213-011-2165-z. Epub 2011 Jan 15. Psychopharmacology (Berl). 2011. PMID: 21234549 Clinical Trial.

10

GABA_A receptor occupancy by subtype selective GABA_Aα2,3 modulators: PET studies in humans.

Jucaite A, Cselényi Z, Lappalainen J, McCarthy DJ, Lee CM, Nyberg S, Varnäs K, Stenkrona P, Halldin C, Cross A, Farde L. Jucaite A, et al. Among authors: nyberg s. Psychopharmacology (Berl). 2017 Feb;234(4):707-716. doi: 10.1007/s00213-016-4506-4. Epub 2016 Dec 24. Psychopharmacology (Berl). 2017. PMID: 28013354 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters